I’ve heard folks within the ageing area describe GLP-1s as longevity medicine for some time now (even when they solely profit people who find themselves chubby or diabetic within the first place). This newest announcement comes after we’ve seen a raft of different advantages related to taking these medicine. However there are additionally some bizarre unwanted side effects.
Up to now, GLP-1 agonist medicine—which repress starvation—have been permitted for treating diabetes, power kidney illness, and weight problems, and so they may also be prescribed for some people who find themselves chubby or vulnerable to sure cardiovascular illnesses. However there’s analysis to counsel they could additionally assist folks with substance-use problems, and so they’ve been investigated for potential advantages in neurodegenerative illness and most cancers.
And a lot of persons are taking them. In keeping with a current Gallup ballot, 11% of Individuals are taking a GLP-1 drug for weight reduction, up from 3% in 2024. And 15% of Individuals say they’ve used one for weight reduction in some unspecified time in the future.
They are often extremely efficient. However, like several drug, they’ll include unwanted side effects. And we’re nonetheless determining precisely what these may be, and the way widespread they’re.
The commonest unwanted side effects are gastrointestinal—nausea, vomiting, diarrhea, and constipation. The medicine have additionally been linked to pancreatitis and gallstone illness.
Some declare that, in uncommon instances, the medicine may trigger injury to nerves behind the attention. Dozens of persons are suing Novo and Eli Lilly after growing a situation that may result in sudden imaginative and prescient loss. They’re claiming that their signs had been introduced on by the GLP-1 medicine that these firms manufacture. Each firms dispute the claims. Analysis into the hyperlink is blended.
We’re nonetheless attending to grips with the consequences of weight-loss medicine on hair and nails, too. When Savanna Vidal on the George Washington College Faculty of Medication and Well being Sciences in Washington, DC, and colleagues assessed digital well being information from 67 US health-care organizations, they discovered that GLP-1 use was related to an elevated threat of hair loss. It’s nonetheless not considered widespread, nonetheless.
And at a convention in Austria final week, one other group introduced the outcomes of a smaller research suggesting that 66% of GLP-1 customers reported at the very least one nail dysfunction—in some instances involving nail detachment. Nail situations had been additionally pretty widespread amongst individuals who didn’t take the medicine, although. The authors don’t declare that the medicine are inflicting nails to fall out (as I’m certain 11% of the American inhabitants shall be relieved to listen to).
![11 social media tendencies each marketer ought to watch in 2026 [new data]](https://blog.aimactgrow.com/wp-content/uploads/2026/09/social20media20trends-1-120x86.png)
